New insight into the causes, consequences, and correction of hematopoietic stem cell aging
Experimental Hematology · 2023
DOI: 10.1016/j.exphem.2023.07.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Hematology, 2023. Verfasst von Els Mansell und 4 weiteren Autor:innen. Beteiligte Einrichtung: Erasmus MC Hematology, Rotterdam, The Netherlands; Division of Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden. Electronic address…. Hauptthemen laut MEDLINE: Aging, Hematologic Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Aging of hematopoietic stem cells (HSCs) is characterized by lineage bias, increased clonal expansion, and functional decrease. At the molecular level, aged HSCs typically display metabolic dysregulation, upregulation of inflammatory pathways, and downregulation of DNA repair pathways. Cellular aging of HSCs, driven by cell-intrinsic and cell-extrinsic factors, causes a predisposition to anemia, adaptive immune compromise, myelodys, plasia, and malignancy. Most hematologic diseases are strongly associated with age. But what is the biological foundation for decreased fitness with age? And are there therapeutic windows to resolve age-related hematopoietic decline? These questions were the focus of the International Society for Experimental Hematology (ISEH) New Investigator Committee Fall 2022 Webinar. This review touches on the latest insights from two leading laboratories into inflammatory- and niche-driven stem cell aging and includes speculation on strategies to prevent or correct age-related decline in HSC function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Erasmus MC Hematology, Rotterdam, The Netherlands; Division of Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden. Electronic address: s.mansell@erasmusmc.nl.
- Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, England, UK.
- Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany; Division of Experimental Hematology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- The Jackson Laboratory, Bar Harbor, Maine.
Förderung
- NIA NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Mansell, E., Lin, D. S., Loughran, S. J., Milsom, M. D., & Trowbridge, J. J. (2023). New insight into the causes, consequences, and correction of hematopoietic stem cell aging. Experimental Hematology. https://doi.org/10.1016/j.exphem.2023.07.002
Vancouver
Mansell E, Lin DS, Loughran SJ, Milsom MD, Trowbridge JJ. New insight into the causes, consequences, and correction of hematopoietic stem cell aging. Experimental Hematology. 2023. doi:10.1016/j.exphem.2023.07.002
BibTeX
@article{Mansell2023,
author = {Mansell, Els and Lin, Dawn S and Loughran, Stephen J and Milsom, Michael D and Trowbridge, Jennifer J},
title = {New insight into the causes, consequences, and correction of hematopoietic stem cell aging},
journal = {Experimental Hematology},
year = {2023},
doi = {10.1016/j.exphem.2023.07.002}
}
EUVIMED